Publications
Journal Articles
Li, Yuchen, Song, Qingkun and Day, Bryan W. (2019) Phase I and phase II sonidegib and vismodegib clinical trials for the treatment of paediatric and adult MB patients: a systemic review and meta-analysis. Acta Neuropathologica Communications, 7 1: 123. doi:10.1186/s40478-019-0773-8
Day, Bryan W., Lathia, Justin D., Bruce, Zara C., D’Souza, Rochelle C. J., Baumgartner, Ulrich, Ensbey, Kathleen S., Lim, Yi Chieh, Stringer, Brett W., Akgül, Seçkin, Offenhäuser, Carolin, Li, Yuchen, Jamieson, Paul R., Smith, Fiona M., Jurd, Courtney L. R., Robertson, Thomas, Inglis, Po-Ling, Lwin, Zarnie, Jeffree, Rosalind L., Johns, Terrance G., Bhat, Krishna P. L., Rich, Jeremy N., Campbell, Kevin P. and Boyd, Andrew W. (2019) The dystroglycan receptor maintains glioma stem cells in the vascular niche. Acta Neuropathologica, 138 6: 1033-1052. doi:10.1007/s00401-019-02069-x
Lim, Yi Chieh, Quek, Hazel, Offenhäuser, Carolin, Fazry, Shazrul, Boyd, Andrew, Lavin, Martin, Roberts, Tara and Day, Bryan (2018) ATM inhibition prevents interleukin-6 from contributing to the proliferation of glioblastoma cells after ionizing radiation. Journal of Neuro-Oncology, 138 3: 509-518. doi:10.1007/s11060-018-2838-0
Betts, Joshua A., Moradi Marjaneh, Mahdi, Al-Ejeh, Fares, Lim, Yi Chieh, Shi, Wei, Sivakumaran, Haran, Tropee, Romain, Patch, Ann.-Marie, Clark, Michael B., Bartonicek, Nenad, Wiegmans, Adrian P., Hillman, Kristine M., Kaufmann, Susanne, Bain, Amanda L., Gloss, Brian S., Crawford, Joanna, Kazakoff, Stephen, Wani, Shivangi, Wen Shu W., Day, Bryan, Moller, Andreas, Cloonan, Nicole, Pearson,John, Brown, Melissa A., Mercer, Timothy R., Waddell, Nicola, Khanna, Kum Kum, Dray, Eloise, Dinger, Marcel E., Edwards, Stacey L. and French, Juliet D. (2017) Long noncoding RNAs CUPID1 and CUPID2 mediate breast cancer risk at 11q13 by modulating the response to DNA damage. American Journal of Human Genetics, 101 2: 255-266. doi:10.1016/j.ajhg.2017.07.007
Stringer, Brett W., Bunt, Jens, Day, Bryan W., Barry, Guy, Jamieson, Paul R., Ensbey, Kathleen S., Bruce, Zara C., Goasdoué, Kate, Vidal, Helene, Charmsaz, Sara, Smith, Fiona M., Cooper, Leanne T., Piper, Michael, Boyd, Andrew W. and Richards, Linda J. (2016) Nuclear factor one B (NFIB) encodes a subtype-specific tumour suppressor in glioblastoma. Oncotarget, 7 20: 29306-12320. doi:10.18632/oncotarget.8720
Grundy, Thomas James, De Leon, Ellen, Griffin, Kaitlyn Rose, Stringer, Brett William, Day, Bryan William, Fabry, Ben, Cooper-White, Justin and O'Neill, Geraldine Margaret (2016) Differential response of patient-derived primary glioblastoma cells to environmental stiffness. Scientific Reports, 6 23353: 1-10. doi:10.1038/srep23353
Puttick, Simon, Stringer, Brett W., Day, Bryan W., Bruce, Zara C., Ensbey, Kathleen S., Mardon, Karine, Cowin, Gary J., Thurecht, Kristofer J, Whittaker, Andrew K., Fay, Michael, Boyd, Andrew W. and Rose, Stephen (2015) EphA2 as a Diagnostic Imaging Target in Glioblastoma: A Positron Emission Tomography/Magnetic Resonance Imaging Study. Molecular Imaging, 14 6: 385-395. doi:10.2310/7290.2015.00008
Rundle-Thiele, Dayle, Day, Bryan, Stringer, Brett, Fay, Michael, Martin, Jennifer, Jeffree, Rosalind L., Thomas, Paul, Bell, Christopher, Salvado, Olivier, Gal, Yaniv, Coulthard, Alan, Crozier, Stuart and Rose, Stephen (2015) Using the apparent diffusion coefficient to identifying MGMT promoter methylation status early in glioblastoma: importance of analytical method. Journal of Medical Radiation Sciences, 62 2: 92-98. doi:10.1002/jmrs.103
Day, B. W., Stringer, B. W. and Boyd, A. W. (2014) Eph receptors as therapeutic targets in glioblastoma. British Journal of Cancer, 111 7: 1255-1261. doi:10.1038/bjc.2014.73
Lim, Yi Chieh, Roberts, Tara L., Day, Bryan W., Stringer, Brett W., Kozlov, Sergei, Fazry, Shazrul, Bruce, Zara C., Ensbey, Kathleen S., Walker, David G., Boyd, Andrew W. and Lavin, Martin F. (2014) Increased sensitivity to ionizing radiation by targeting the homologous recombination pathway in glioma initiating cells. Molecular Oncology, 8 8: 1603-1615. doi:10.1016/j.molonc.2014.06.012
Al-Ejeh, Fares, Offenhäuser, Carolin, Lim, Yi Chieh, Stringer, Brett W., Day, Bryan W. and Boyd, Andrew W. (2014) Eph family co-expression patterns define unique clusters predictive of cancer phenotype. Growth Factors, 32 6: 254-264. doi:10.3109/08977194.2014.984807
Day, Bryan W., Stringer, Brett W., Wilson, John, Jeffree, Rosalind L., Jamieson, Paul R., Ensbey, Kathleen S., Bruce, Zara C., Inglis, Po, Allan, Suzanne, Winter, Craig, Tollesson, Gert, Campbell, Scott, Lucas, Peter, Findlay, Wendy, Kadrian, David, Johnson, David, Robertson, Thomas, Johns, Terrance G., Bartlett, Perry F., Osborne, Geoffrey W. and Boyd, Andrew W. (2013) Glioma surgical aspirate: a viable source of tumor tissue for experimental research. Cancers, 5 2: 357-371. doi:10.3390/cancers5020357
Day, Bryan W., Stringer, Brett W., Al-Ejeh, Fares, Ting, Michael J., Wilson, John, Ensbey, Kathleen S., Jamieson, Paul R., Bruce, Zara C., Lim, Yi Chieh, Offenhauser, Carolin, Charmsaz, Sara, Cooper, Leanne T., Ellacott, Jennifer K., Harding, Angus, Leveque, Lucie, Inglis, Po, Allan, Suzanne, Walker, David G., Lackmann, Martin, Osborne, Geoffrey, Khanna, Kum Kum, Reynolds, Brent A., Lickliter, Jason D. and Boyd, Andrew W. (2013) EphA3 Maintains Tumorigenicity and Is a Therapeutic Target in Glioblastoma Multiforme. Cancer Cell, 23 2: 238-248. doi:10.1016/j.ccr.2013.01.007
Day, Bryan W., Stringer, Brett W., Spanevello, Mark D., Charmsaz, Sara, Jamieson, Paul R., Ensbey, Kathleen S., Carter, Jacinta C., Cox, Joanne M., Ellis, Vicky J., Brown, Christopher L., Walker, David G., Inglis, Po L., Allan, Suzanne, Reynolds, Brent A., Lickliter, Jason D. and Boyd, Andrew W. (2011) ELK4 neutralization sensitizes glioblastoma to apoptosis through downregulation of the anti-apoptotic protein Mcl-1. Neuro-Oncology, 13 11: 1202-1212. doi:10.1093/neuonc/nor119
Ting, Michael J., Day, Bryan W., Spanevello, Mark D. and Boyd, Andrew W. (2010) Activation of ephrin A proteins influences hematopoietic stem cell adhesion and trafficking patterns. Experimental Hematology, 38 11: 1087-1098. doi:10.1016/j.exphem.2010.07.007
McCarron, JK, Stringer, BW, Day, BW and Boyd, AW (2010) Ephrin expression and function in cancer. Future Oncology, 6 1: 165-176. doi:10.2217/FON.09.146
Day, B, To, C, Himanen, JP, Smith, FM, Nikolov, DB, Boyd, AW and Lackmann, M (2005) Three distinct molecular surfaces in ephrin-A5 are essential for a functional interaction with EphA3. Journal of Biological Chemistry, 280 28: 26526-26532. doi:10.1074/jbc.M504972200